RVMD – Revolution Medicines, Inc.
Float Short %
10.58
Margin Of Safety %
Put/Call OI Ratio
0.33
EPS Next Q Diff
-0.04
EPS Last/This Y
-1.96
EPS This/Next Y
-0.75
Price
80.06
Target Price
81.15
Analyst Recom
1
Performance Q
95.55
Relative Volume
1.11
Beta
0.99
Ticker: RVMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | RVMD | 62.72 | 0.37 | 0.09 | 43126 |
| 2025-11-11 | RVMD | 64.13 | 0.37 | 0.05 | 43176 |
| 2025-11-12 | RVMD | 65.82 | 0.37 | 0.01 | 43268 |
| 2025-11-13 | RVMD | 64.37 | 0.37 | 0.18 | 43497 |
| 2025-11-14 | RVMD | 67.77 | 0.37 | 0.31 | 43537 |
| 2025-11-17 | RVMD | 69.14 | 0.37 | 0.30 | 44118 |
| 2025-11-18 | RVMD | 70.56 | 0.37 | 0.20 | 44337 |
| 2025-11-19 | RVMD | 70.52 | 0.37 | 0.17 | 44829 |
| 2025-11-20 | RVMD | 69.86 | 0.36 | 0.39 | 45144 |
| 2025-11-21 | RVMD | 70.88 | 0.37 | 0.45 | 45266 |
| 2025-11-24 | RVMD | 73.66 | 0.35 | 0.61 | 41690 |
| 2025-11-25 | RVMD | 76.37 | 0.35 | 0.31 | 42191 |
| 2025-11-26 | RVMD | 77.53 | 0.35 | 0.67 | 42805 |
| 2025-12-01 | RVMD | 75.8 | 0.36 | 0.63 | 43731 |
| 2025-12-02 | RVMD | 75.34 | 0.36 | 2.43 | 43997 |
| 2025-12-03 | RVMD | 77.7 | 0.36 | 0.14 | 43941 |
| 2025-12-04 | RVMD | 78.47 | 0.34 | 0.06 | 46243 |
| 2025-12-05 | RVMD | 79.66 | 0.33 | 0.09 | 48235 |
| 2025-12-08 | RVMD | 80.06 | 0.33 | 0.24 | 48276 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | RVMD | 62.73 | -36.6 | -307.8 | -5.32 |
| 2025-11-11 | RVMD | 64.08 | -40.3 | -299.0 | -5.49 |
| 2025-11-12 | RVMD | 65.81 | -40.3 | -305.5 | -5.49 |
| 2025-11-13 | RVMD | 64.36 | -40.3 | -230.7 | -5.49 |
| 2025-11-14 | RVMD | 67.74 | -40.3 | -343.8 | -5.49 |
| 2025-11-17 | RVMD | 69.11 | -40.3 | -294.6 | -5.49 |
| 2025-11-18 | RVMD | 70.56 | -40.5 | -296.0 | -5.50 |
| 2025-11-19 | RVMD | 70.53 | -40.5 | -263.6 | -5.50 |
| 2025-11-20 | RVMD | 69.83 | -42.3 | -249.3 | -5.57 |
| 2025-11-21 | RVMD | 70.84 | -42.3 | -286.5 | -5.57 |
| 2025-11-24 | RVMD | 73.64 | -42.3 | -323.4 | -5.57 |
| 2025-11-25 | RVMD | 76.32 | -42.6 | -318.3 | -5.54 |
| 2025-11-26 | RVMD | 77.52 | -42.6 | -287.9 | -5.54 |
| 2025-12-01 | RVMD | 75.79 | -42.6 | -227.2 | -5.54 |
| 2025-12-02 | RVMD | 75.31 | -42.6 | -255.6 | -5.54 |
| 2025-12-03 | RVMD | 77.69 | -42.6 | -311.4 | -5.54 |
| 2025-12-04 | RVMD | 78.50 | -42.6 | -280.2 | -5.54 |
| 2025-12-05 | RVMD | 79.64 | -42.6 | -286.4 | -5.54 |
| 2025-12-08 | RVMD | 80.06 | -42.6 | - | -5.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | RVMD | -0.85 | -1.90 | 11.56 |
| 2025-11-11 | RVMD | -0.85 | -1.90 | 11.56 |
| 2025-11-12 | RVMD | -0.85 | -1.90 | 10.76 |
| 2025-11-13 | RVMD | -1.00 | -1.90 | 10.76 |
| 2025-11-14 | RVMD | -1.00 | -1.90 | 10.75 |
| 2025-11-17 | RVMD | -1.09 | 4.43 | 10.75 |
| 2025-11-18 | RVMD | -1.09 | 4.43 | 10.92 |
| 2025-11-19 | RVMD | -0.98 | 4.43 | 10.92 |
| 2025-11-20 | RVMD | -1.10 | 4.43 | 10.97 |
| 2025-11-21 | RVMD | -1.07 | 4.43 | 10.97 |
| 2025-11-24 | RVMD | -1.07 | 1.27 | 10.97 |
| 2025-11-25 | RVMD | -1.07 | 1.27 | 10.97 |
| 2025-11-26 | RVMD | -1.31 | 1.27 | 10.64 |
| 2025-12-01 | RVMD | -1.31 | 1.22 | 10.58 |
| 2025-12-02 | RVMD | -1.36 | 1.22 | 10.58 |
| 2025-12-03 | RVMD | -1.36 | 1.22 | 10.58 |
| 2025-12-04 | RVMD | -1.36 | 1.22 | 10.58 |
| 2025-12-05 | RVMD | -1.36 | 1.22 | 10.58 |
| 2025-12-08 | RVMD | -1.36 | 1.24 | 10.58 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.61
Avg. EPS Est. Current Quarter
-1.6
Avg. EPS Est. Next Quarter
-1.66
Insider Transactions
-1.36
Institutional Transactions
1.24
Beta
0.99
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
Fair Value
Quality Score
5
Growth Score
22
Sentiment Score
50
Actual DrawDown %
-0.3
Max Drawdown 5-Year %
-73.3
Target Price
81.15
P/E
Forward P/E
PEG
P/S
P/B
9.51
P/Free Cash Flow
EPS
-5.18
Average EPS Est. Cur. Y
-5.54
EPS Next Y. (Est.)
-6.29
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.11
Return on Equity vs Sector %
-87.1
Return on Equity vs Industry %
-72.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.22
EBIT Estimation
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 809
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading